(Q56944822)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

editorial

0 references

title

Glycoprotein IIb/IIIa inhibitors: current indications and future prospects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

J P Reginelli

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

252-254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Recognition of the importance of embolization in atherosclerotic vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Influence of a platelet GPIIb/IIIa receptor antagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocardial Tc-99m sestamibi scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Coronary angiographic findings and troponin T in patients with unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Evaluation of a GPIIb/IIIa antagonist YM337 in a primate model of middle cerebral artery thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

Glycoprotein IIb/IIIa antagonists induce apoptosis in rat cardiomyocytes by caspase-3 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900527-1

10.1016/S0002-9343(00)00527-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10974193%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference